Cargando…
Current progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the most common primary liver cancer worldwide. The onset of the disease is occult and develops rapidly. As a result, the disease is often detected when it is already in advanced stages, resulting in patients losing the best opportunity for liver transplantation and...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Portland Press Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821949/ https://www.ncbi.nlm.nih.gov/pubmed/35075482 http://dx.doi.org/10.1042/BSR20212304 |